CN Stock MarketDetailed Quotes

300147 Xiangxue Pharmaceutical

Watchlist
  • 3.50
  • +0.03+0.86%
Market Closed Jul 12 15:00 CST
2.31BMarket Cap-5392P/E (TTM)

Xiangxue Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-17.99%117.27M
-10.32%149.32M
-21.56%130.96M
-40.93%127.45M
-59.93%142.99M
-15.10%166.5M
1.30%166.96M
0.50%215.76M
-25.01%356.83M
-67.59%196.12M
Transactional financial assets
7,158.71%4M
----
----
----
-99.91%55.11K
-99.81%125.98K
-92.50%231.17K
1,509.86%75.89M
1,213.27%58.61M
239.38%65.63M
Notes receivable and accounts receivable
13.41%832.14M
16.45%793.8M
46.85%803.78M
-31.13%776.82M
-37.00%733.77M
-38.54%681.65M
-51.41%547.36M
2.42%1.13B
2.39%1.16B
6.75%1.11B
-Notes receivable
-33.32%87.45M
8.81%88.86M
5,546.15%151.28M
1,149.32%144.47M
--131.16M
555.27%81.66M
--2.68M
--11.56M
--0
--12.46M
-Accounts receivable
23.58%744.69M
17.49%704.94M
19.80%652.5M
-43.36%632.35M
-48.26%602.61M
-45.29%599.99M
-51.65%544.68M
1.37%1.12B
2.39%1.16B
5.55%1.1B
Other receivables (including interest and dividends)
-20.76%51.78M
-31.28%52.55M
-23.80%54.21M
22.38%55.55M
-15.14%65.35M
-77.90%76.47M
-31.38%71.14M
-59.74%45.39M
-90.91%77.01M
-66.66%346.04M
-Dividend receivable
--22.44M
--22.44M
----
----
----
----
----
----
----
----
-Other receivable
----
----
----
----
----
----
----
-46.51%45.39M
----
----
Advance payment
-30.12%27.21M
-55.08%24.55M
-54.42%22.65M
8.09%29.77M
-59.42%38.93M
-28.10%54.66M
-18.85%49.69M
-55.41%27.54M
177.08%95.93M
37.11%76.02M
Inventories
-19.71%407.6M
-11.94%411.3M
18.25%504.96M
-27.25%490.78M
-28.45%507.63M
-38.66%467.07M
-50.43%427.03M
-20.65%674.65M
-20.16%709.49M
-9.33%761.46M
Receivable financing
----
-96.79%642.66K
-95.45%2.34M
-88.37%7.9M
-90.06%8.04M
-81.98%20.05M
-23.26%51.43M
-13.34%67.87M
-35.44%80.9M
-40.58%111.25M
Assets held for sale
168.80%311.56M
133.79%323.74M
128.40%291.2M
-12.36%89.1M
8.99%115.91M
-30.39%138.48M
-9.48%127.5M
-30.17%101.66M
-19.39%106.35M
50.53%198.93M
Other current assets
-17.84%72.22M
-22.38%68.45M
-11.26%78.55M
-70.47%80.12M
-64.74%87.9M
-60.16%88.18M
-36.78%88.51M
111.72%271.35M
174.64%249.28M
85.15%221.36M
Total current assets
7.24%1.82B
7.75%1.82B
23.45%1.89B
-36.45%1.66B
-41.34%1.7B
-45.13%1.69B
-42.67%1.53B
-3.32%2.61B
-22.41%2.9B
-23.53%3.09B
Non Current assets
Other equity investment
-2.76%86.53M
-2.76%86.53M
-10.10%88.98M
-10.10%88.98M
-10.10%88.98M
-10.10%88.98M
-67.33%98.98M
-62.36%98.98M
-62.47%98.98M
-62.47%98.98M
Other non-current financial assets
1.97%48.27M
1.89%48.24M
-14.69%45.95M
-13.96%47.33M
-15.39%47.34M
-16.10%47.35M
-49.86%53.86M
-48.81%55.01M
11.55%55.95M
12.51%56.43M
Investment real estate
----
----
----
----
----
----
----
11.84%245.3M
11.96%247.13M
11.89%248.53M
Long-term equity investment
-86.87%44.18M
-86.98%43.71M
-67.52%107.08M
178.97%308.47M
201.41%336.38M
192.43%335.7M
171.80%329.72M
-11.44%110.57M
-13.53%111.6M
-11.06%114.79M
Fixed assets
----
----
----
----
----
----
----
100.20%4B
----
----
Constru in process
----
----
----
----
----
----
----
-47.78%2B
----
----
Productive biological assets
-3.04%609.25K
-3.24%560.59K
1.41%538K
-17.83%675K
-22.08%628.35K
-27.05%579.35K
-31.77%530.51K
7.32%821.5K
7.03%806.36K
7.16%794.22K
Intangible assets
-4.67%907.42M
-4.65%919.28M
-4.70%929.27M
-6.92%941.05M
-7.54%951.92M
-6.79%964.09M
-8.20%975.11M
-5.58%1.01B
69.37%1.03B
-4.61%1.03B
Development expenditure
8.83%445.5M
8.33%436.49M
7.79%422.59M
0.85%415.85M
0.92%409.34M
1.89%402.93M
-5.60%392.07M
1.79%412.35M
5.90%405.63M
11.12%395.46M
Goodwill
0.00%199.72M
0.00%199.72M
0.00%199.72M
-25.09%199.72M
-25.09%199.72M
-25.09%199.72M
-68.13%199.72M
-57.45%266.6M
-57.45%266.6M
-57.45%266.6M
Long deferred expense
2.80%38.19M
6.86%40.31M
9.38%37.38M
28.62%37.86M
18.03%37.15M
10.76%37.72M
-5.96%34.17M
-20.97%29.43M
-25.32%31.48M
-13.96%34.06M
Deferred tax assets
8.94%28.72M
8.02%28.42M
74.71%26.57M
58.43%28.5M
36.59%26.37M
35.79%26.31M
-24.00%15.21M
-11.66%17.99M
0.81%19.3M
-14.88%19.37M
Usufruct assets
39.31%35.35M
36.55%36.16M
1,313.63%23.39M
529.46%24.27M
458.67%25.38M
399.97%26.48M
-1.32%1.65M
59.53%3.86M
--4.54M
47.41%5.3M
Other non current assets
31.86%38.87M
6.87%33.08M
-56.13%34.1M
-60.70%34.39M
-53.26%29.48M
-55.45%30.95M
-61.42%77.73M
-58.00%87.51M
-64.80%63.07M
-71.23%69.48M
Total non current assets
-7.03%6.42B
-6.99%6.46B
-15.69%6.58B
-17.97%6.84B
-16.56%6.9B
-8.70%6.94B
-12.97%7.8B
-6.44%8.33B
34.66%8.27B
-5.56%7.6B
Total assets
-4.21%8.24B
-4.10%8.28B
-9.27%8.47B
-22.37%8.49B
-22.99%8.6B
-19.22%8.63B
-19.78%9.33B
-5.72%10.94B
13.08%11.17B
-11.56%10.69B
Liabilities
Current liabilities
Short term loan
-24.49%1.49B
-22.22%1.5B
-18.37%1.51B
-39.25%1.51B
-21.52%1.98B
-21.90%1.93B
-11.25%1.85B
2.72%2.48B
4.12%2.52B
-14.40%2.47B
Notes payable and accounts payable
9.31%1.1B
9.94%1.09B
40.35%1.05B
7.38%1.03B
-2.59%1.01B
-23.92%988.95M
-27.52%748.71M
6.47%959.01M
13.54%1.04B
62.27%1.3B
-Notes payable
-95.76%518.22K
-86.17%2.48M
167.95%9.19M
1,686.76%10.73M
13.28%12.21M
85.21%17.95M
-98.54%3.43M
-99.52%600.3K
-92.45%10.78M
-92.25%9.69M
-Accounts payable
10.59%1.1B
11.72%1.08B
39.76%1.04B
6.32%1.02B
-2.76%996.23M
-24.74%971M
-6.54%745.28M
23.41%958.41M
33.20%1.02B
90.87%1.29B
Contract liabilities
-21.17%138.3M
-35.24%161.24M
35.17%101.95M
49.43%126.27M
139.15%175.43M
112.11%248.99M
-24.01%75.42M
-9.08%84.5M
-66.35%73.36M
38.09%117.38M
Advance receipts
--0
96.21%1.57M
----
----
----
--798.17K
----
----
----
----
Salaries payable
-7.89%33.59M
29.93%44.54M
27.88%42.48M
12.51%39.02M
26.16%36.47M
-1.86%34.28M
25.48%33.22M
34.66%34.68M
7.04%28.91M
13.08%34.93M
Taxs payable
93.19%66.66M
110.22%70.63M
121.02%57.11M
97.21%50.35M
29.79%34.5M
5.17%33.6M
78.80%25.84M
41.98%25.53M
7.88%26.59M
-5.51%31.95M
Other payable (including interest and dividends)
6.61%1.87B
3.33%1.86B
-28.05%1.8B
-32.33%1.75B
-32.01%1.75B
-2.53%1.8B
-5.76%2.5B
7.29%2.58B
321.71%2.58B
-33.80%1.85B
-Dividend payable
----
----
----
----
----
----
-39.35%15.67M
-39.35%15.67M
----
----
-Other payable
----
----
----
----
----
----
----
7.79%2.56B
----
----
Hold and for sell liabilities
-7.97%29.96M
-29.99%26.21M
3.69%35.24M
-9.00%33.02M
-20.92%32.55M
-57.84%37.43M
7.96%33.99M
-3.04%36.29M
44.16%41.17M
171.52%88.8M
Non current liabilities due within one year
335.04%343.34M
330.08%343.95M
-49.44%118.13M
-47.23%156.22M
-76.92%78.92M
-82.25%79.97M
15.39%233.66M
66.85%296.05M
216.13%341.94M
232.97%450.5M
Other current liabilities
-13.76%77.64M
-18.40%65.68M
963.21%85.83M
978.50%95.27M
904.16%90.02M
426.71%80.49M
-26.06%8.07M
-23.69%8.83M
-62.64%8.97M
55.31%15.28M
Total current liabilities
-0.64%5.15B
-1.37%5.16B
-12.87%4.8B
-26.48%4.78B
-22.05%5.19B
-17.64%5.23B
-10.50%5.51B
6.94%6.5B
52.10%6.65B
-6.60%6.35B
Current liabilities
Long term loan
28.26%547.27M
30.23%556M
59.97%815.39M
43.20%780.44M
-30.77%426.68M
-19.28%426.93M
-19.51%509.71M
-16.04%544.98M
-23.64%616.29M
-27.12%528.92M
Long term account payable
----
----
----
----
----
----
----
--0
----
----
Specific account payable
----
----
----
----
----
----
----
62.53%124.13M
----
----
Estimate liabilities
-43.89%28.78M
-44.03%27.78M
43.36%64.22M
32.38%59.3M
209.33%51.29M
199.33%49.63M
--44.8M
3.54%44.8M
-58.20%16.58M
-54.03%16.58M
Deferred tax liabilities
--9.46M
--9.46M
----
----
----
----
721.40%5.24M
508.73%5.41M
10,983.45%2.6M
15,770.48%3.73M
Long term deferred income
-3.63%60.94M
0.12%60.42M
-2.42%59.39M
-8.86%60.41M
13.62%63.23M
-8.07%60.35M
-20.92%60.86M
-14.31%66.28M
-25.52%55.65M
-13.23%65.65M
Lease liabilities
44.56%32.29M
40.13%34.92M
1,361.56%12.93M
1,270.10%23.13M
882.14%22.34M
956.45%24.92M
--884.54K
89.74%1.69M
--2.27M
1.59%2.36M
Total non current liabilities
15.82%802.68M
18.10%805.73M
44.89%1.08B
33.77%1.05B
-13.57%693.07M
0.55%682.26M
-26.68%746.59M
-26.79%787.29M
-34.25%801.9M
-40.87%678.52M
Total liabilities
1.30%5.96B
0.88%5.97B
-5.98%5.88B
-19.97%5.83B
-21.14%5.88B
-15.89%5.92B
-12.80%6.26B
1.87%7.29B
33.27%7.45B
-11.55%7.03B
Shareholders equity
Paid-in capital
0.00%661.28M
0.00%661.28M
0.00%661.28M
0.00%661.28M
-0.01%661.28M
-0.01%661.28M
-0.01%661.28M
-0.01%661.28M
-0.02%661.36M
-0.02%661.36M
Capital reserve funds
0.00%2.15B
0.00%2.15B
0.00%2.15B
0.00%2.15B
-0.01%2.15B
-0.01%2.15B
-0.22%2.15B
-0.13%2.15B
0.32%2.15B
0.50%2.15B
Surplus reserve funds
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
Retained profit
-72.19%-1.02B
-64.92%-987.43M
-180.40%-744.79M
-383.72%-664.71M
-2,684.58%-594.18M
-775.16%-598.72M
-136.03%-265.62M
-117.83%-137.42M
-102.86%-21.34M
-111.27%-68.41M
Less:Treasury stock
0.00%8.5M
0.00%8.5M
0.00%8.5M
0.00%8.5M
-3.12%8.5M
-3.12%8.5M
-57.73%8.5M
-57.73%8.5M
-57.18%8.77M
-57.18%8.77M
Other composite income
117.72%1.7M
132.60%1.69M
-311.36%-7.96M
-389.91%-7.9M
-600.37%-9.58M
-351.09%-5.19M
-23.22%3.77M
-31.43%2.72M
-54.48%1.91M
-50.81%2.07M
Shareholders equity without minority interests
-18.11%1.89B
-16.55%1.92B
-18.53%2.16B
-19.38%2.24B
-20.21%2.31B
-18.90%2.31B
-27.35%2.65B
-24.50%2.78B
-20.60%2.89B
-18.72%2.84B
Minority interests
-5.00%395.97M
-5.94%388.52M
-0.11%427.23M
-51.89%420.65M
-49.46%416.79M
-49.15%413.05M
-47.48%427.69M
13.41%874.37M
28.04%824.71M
27.61%812.23M
Total shareholder equity
-16.10%2.29B
-14.94%2.31B
-15.97%2.58B
-27.17%2.66B
-26.70%2.72B
-25.62%2.72B
-31.03%3.08B
-17.93%3.65B
-13.29%3.72B
-11.59%3.66B
Total liabilityies and equity
-4.21%8.24B
-4.10%8.28B
-9.27%8.47B
-22.37%8.49B
-22.99%8.6B
-19.22%8.63B
-19.78%9.33B
-5.72%10.94B
13.08%11.17B
-11.56%10.69B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Reservations with explanatory notes
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Beijing Dahua International Accounting Firm (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -17.99%117.27M-10.32%149.32M-21.56%130.96M-40.93%127.45M-59.93%142.99M-15.10%166.5M1.30%166.96M0.50%215.76M-25.01%356.83M-67.59%196.12M
Transactional financial assets 7,158.71%4M-------------99.91%55.11K-99.81%125.98K-92.50%231.17K1,509.86%75.89M1,213.27%58.61M239.38%65.63M
Notes receivable and accounts receivable 13.41%832.14M16.45%793.8M46.85%803.78M-31.13%776.82M-37.00%733.77M-38.54%681.65M-51.41%547.36M2.42%1.13B2.39%1.16B6.75%1.11B
-Notes receivable -33.32%87.45M8.81%88.86M5,546.15%151.28M1,149.32%144.47M--131.16M555.27%81.66M--2.68M--11.56M--0--12.46M
-Accounts receivable 23.58%744.69M17.49%704.94M19.80%652.5M-43.36%632.35M-48.26%602.61M-45.29%599.99M-51.65%544.68M1.37%1.12B2.39%1.16B5.55%1.1B
Other receivables (including interest and dividends) -20.76%51.78M-31.28%52.55M-23.80%54.21M22.38%55.55M-15.14%65.35M-77.90%76.47M-31.38%71.14M-59.74%45.39M-90.91%77.01M-66.66%346.04M
-Dividend receivable --22.44M--22.44M--------------------------------
-Other receivable -----------------------------46.51%45.39M--------
Advance payment -30.12%27.21M-55.08%24.55M-54.42%22.65M8.09%29.77M-59.42%38.93M-28.10%54.66M-18.85%49.69M-55.41%27.54M177.08%95.93M37.11%76.02M
Inventories -19.71%407.6M-11.94%411.3M18.25%504.96M-27.25%490.78M-28.45%507.63M-38.66%467.07M-50.43%427.03M-20.65%674.65M-20.16%709.49M-9.33%761.46M
Receivable financing -----96.79%642.66K-95.45%2.34M-88.37%7.9M-90.06%8.04M-81.98%20.05M-23.26%51.43M-13.34%67.87M-35.44%80.9M-40.58%111.25M
Assets held for sale 168.80%311.56M133.79%323.74M128.40%291.2M-12.36%89.1M8.99%115.91M-30.39%138.48M-9.48%127.5M-30.17%101.66M-19.39%106.35M50.53%198.93M
Other current assets -17.84%72.22M-22.38%68.45M-11.26%78.55M-70.47%80.12M-64.74%87.9M-60.16%88.18M-36.78%88.51M111.72%271.35M174.64%249.28M85.15%221.36M
Total current assets 7.24%1.82B7.75%1.82B23.45%1.89B-36.45%1.66B-41.34%1.7B-45.13%1.69B-42.67%1.53B-3.32%2.61B-22.41%2.9B-23.53%3.09B
Non Current assets
Other equity investment -2.76%86.53M-2.76%86.53M-10.10%88.98M-10.10%88.98M-10.10%88.98M-10.10%88.98M-67.33%98.98M-62.36%98.98M-62.47%98.98M-62.47%98.98M
Other non-current financial assets 1.97%48.27M1.89%48.24M-14.69%45.95M-13.96%47.33M-15.39%47.34M-16.10%47.35M-49.86%53.86M-48.81%55.01M11.55%55.95M12.51%56.43M
Investment real estate ----------------------------11.84%245.3M11.96%247.13M11.89%248.53M
Long-term equity investment -86.87%44.18M-86.98%43.71M-67.52%107.08M178.97%308.47M201.41%336.38M192.43%335.7M171.80%329.72M-11.44%110.57M-13.53%111.6M-11.06%114.79M
Fixed assets ----------------------------100.20%4B--------
Constru in process -----------------------------47.78%2B--------
Productive biological assets -3.04%609.25K-3.24%560.59K1.41%538K-17.83%675K-22.08%628.35K-27.05%579.35K-31.77%530.51K7.32%821.5K7.03%806.36K7.16%794.22K
Intangible assets -4.67%907.42M-4.65%919.28M-4.70%929.27M-6.92%941.05M-7.54%951.92M-6.79%964.09M-8.20%975.11M-5.58%1.01B69.37%1.03B-4.61%1.03B
Development expenditure 8.83%445.5M8.33%436.49M7.79%422.59M0.85%415.85M0.92%409.34M1.89%402.93M-5.60%392.07M1.79%412.35M5.90%405.63M11.12%395.46M
Goodwill 0.00%199.72M0.00%199.72M0.00%199.72M-25.09%199.72M-25.09%199.72M-25.09%199.72M-68.13%199.72M-57.45%266.6M-57.45%266.6M-57.45%266.6M
Long deferred expense 2.80%38.19M6.86%40.31M9.38%37.38M28.62%37.86M18.03%37.15M10.76%37.72M-5.96%34.17M-20.97%29.43M-25.32%31.48M-13.96%34.06M
Deferred tax assets 8.94%28.72M8.02%28.42M74.71%26.57M58.43%28.5M36.59%26.37M35.79%26.31M-24.00%15.21M-11.66%17.99M0.81%19.3M-14.88%19.37M
Usufruct assets 39.31%35.35M36.55%36.16M1,313.63%23.39M529.46%24.27M458.67%25.38M399.97%26.48M-1.32%1.65M59.53%3.86M--4.54M47.41%5.3M
Other non current assets 31.86%38.87M6.87%33.08M-56.13%34.1M-60.70%34.39M-53.26%29.48M-55.45%30.95M-61.42%77.73M-58.00%87.51M-64.80%63.07M-71.23%69.48M
Total non current assets -7.03%6.42B-6.99%6.46B-15.69%6.58B-17.97%6.84B-16.56%6.9B-8.70%6.94B-12.97%7.8B-6.44%8.33B34.66%8.27B-5.56%7.6B
Total assets -4.21%8.24B-4.10%8.28B-9.27%8.47B-22.37%8.49B-22.99%8.6B-19.22%8.63B-19.78%9.33B-5.72%10.94B13.08%11.17B-11.56%10.69B
Liabilities
Current liabilities
Short term loan -24.49%1.49B-22.22%1.5B-18.37%1.51B-39.25%1.51B-21.52%1.98B-21.90%1.93B-11.25%1.85B2.72%2.48B4.12%2.52B-14.40%2.47B
Notes payable and accounts payable 9.31%1.1B9.94%1.09B40.35%1.05B7.38%1.03B-2.59%1.01B-23.92%988.95M-27.52%748.71M6.47%959.01M13.54%1.04B62.27%1.3B
-Notes payable -95.76%518.22K-86.17%2.48M167.95%9.19M1,686.76%10.73M13.28%12.21M85.21%17.95M-98.54%3.43M-99.52%600.3K-92.45%10.78M-92.25%9.69M
-Accounts payable 10.59%1.1B11.72%1.08B39.76%1.04B6.32%1.02B-2.76%996.23M-24.74%971M-6.54%745.28M23.41%958.41M33.20%1.02B90.87%1.29B
Contract liabilities -21.17%138.3M-35.24%161.24M35.17%101.95M49.43%126.27M139.15%175.43M112.11%248.99M-24.01%75.42M-9.08%84.5M-66.35%73.36M38.09%117.38M
Advance receipts --096.21%1.57M--------------798.17K----------------
Salaries payable -7.89%33.59M29.93%44.54M27.88%42.48M12.51%39.02M26.16%36.47M-1.86%34.28M25.48%33.22M34.66%34.68M7.04%28.91M13.08%34.93M
Taxs payable 93.19%66.66M110.22%70.63M121.02%57.11M97.21%50.35M29.79%34.5M5.17%33.6M78.80%25.84M41.98%25.53M7.88%26.59M-5.51%31.95M
Other payable (including interest and dividends) 6.61%1.87B3.33%1.86B-28.05%1.8B-32.33%1.75B-32.01%1.75B-2.53%1.8B-5.76%2.5B7.29%2.58B321.71%2.58B-33.80%1.85B
-Dividend payable -------------------------39.35%15.67M-39.35%15.67M--------
-Other payable ----------------------------7.79%2.56B--------
Hold and for sell liabilities -7.97%29.96M-29.99%26.21M3.69%35.24M-9.00%33.02M-20.92%32.55M-57.84%37.43M7.96%33.99M-3.04%36.29M44.16%41.17M171.52%88.8M
Non current liabilities due within one year 335.04%343.34M330.08%343.95M-49.44%118.13M-47.23%156.22M-76.92%78.92M-82.25%79.97M15.39%233.66M66.85%296.05M216.13%341.94M232.97%450.5M
Other current liabilities -13.76%77.64M-18.40%65.68M963.21%85.83M978.50%95.27M904.16%90.02M426.71%80.49M-26.06%8.07M-23.69%8.83M-62.64%8.97M55.31%15.28M
Total current liabilities -0.64%5.15B-1.37%5.16B-12.87%4.8B-26.48%4.78B-22.05%5.19B-17.64%5.23B-10.50%5.51B6.94%6.5B52.10%6.65B-6.60%6.35B
Current liabilities
Long term loan 28.26%547.27M30.23%556M59.97%815.39M43.20%780.44M-30.77%426.68M-19.28%426.93M-19.51%509.71M-16.04%544.98M-23.64%616.29M-27.12%528.92M
Long term account payable ------------------------------0--------
Specific account payable ----------------------------62.53%124.13M--------
Estimate liabilities -43.89%28.78M-44.03%27.78M43.36%64.22M32.38%59.3M209.33%51.29M199.33%49.63M--44.8M3.54%44.8M-58.20%16.58M-54.03%16.58M
Deferred tax liabilities --9.46M--9.46M----------------721.40%5.24M508.73%5.41M10,983.45%2.6M15,770.48%3.73M
Long term deferred income -3.63%60.94M0.12%60.42M-2.42%59.39M-8.86%60.41M13.62%63.23M-8.07%60.35M-20.92%60.86M-14.31%66.28M-25.52%55.65M-13.23%65.65M
Lease liabilities 44.56%32.29M40.13%34.92M1,361.56%12.93M1,270.10%23.13M882.14%22.34M956.45%24.92M--884.54K89.74%1.69M--2.27M1.59%2.36M
Total non current liabilities 15.82%802.68M18.10%805.73M44.89%1.08B33.77%1.05B-13.57%693.07M0.55%682.26M-26.68%746.59M-26.79%787.29M-34.25%801.9M-40.87%678.52M
Total liabilities 1.30%5.96B0.88%5.97B-5.98%5.88B-19.97%5.83B-21.14%5.88B-15.89%5.92B-12.80%6.26B1.87%7.29B33.27%7.45B-11.55%7.03B
Shareholders equity
Paid-in capital 0.00%661.28M0.00%661.28M0.00%661.28M0.00%661.28M-0.01%661.28M-0.01%661.28M-0.01%661.28M-0.01%661.28M-0.02%661.36M-0.02%661.36M
Capital reserve funds 0.00%2.15B0.00%2.15B0.00%2.15B0.00%2.15B-0.01%2.15B-0.01%2.15B-0.22%2.15B-0.13%2.15B0.32%2.15B0.50%2.15B
Surplus reserve funds 0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M
Retained profit -72.19%-1.02B-64.92%-987.43M-180.40%-744.79M-383.72%-664.71M-2,684.58%-594.18M-775.16%-598.72M-136.03%-265.62M-117.83%-137.42M-102.86%-21.34M-111.27%-68.41M
Less:Treasury stock 0.00%8.5M0.00%8.5M0.00%8.5M0.00%8.5M-3.12%8.5M-3.12%8.5M-57.73%8.5M-57.73%8.5M-57.18%8.77M-57.18%8.77M
Other composite income 117.72%1.7M132.60%1.69M-311.36%-7.96M-389.91%-7.9M-600.37%-9.58M-351.09%-5.19M-23.22%3.77M-31.43%2.72M-54.48%1.91M-50.81%2.07M
Shareholders equity without minority interests -18.11%1.89B-16.55%1.92B-18.53%2.16B-19.38%2.24B-20.21%2.31B-18.90%2.31B-27.35%2.65B-24.50%2.78B-20.60%2.89B-18.72%2.84B
Minority interests -5.00%395.97M-5.94%388.52M-0.11%427.23M-51.89%420.65M-49.46%416.79M-49.15%413.05M-47.48%427.69M13.41%874.37M28.04%824.71M27.61%812.23M
Total shareholder equity -16.10%2.29B-14.94%2.31B-15.97%2.58B-27.17%2.66B-26.70%2.72B-25.62%2.72B-31.03%3.08B-17.93%3.65B-13.29%3.72B-11.59%3.66B
Total liabilityies and equity -4.21%8.24B-4.10%8.28B-9.27%8.47B-22.37%8.49B-22.99%8.6B-19.22%8.63B-19.78%9.33B-5.72%10.94B13.08%11.17B-11.56%10.69B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Reservations with explanatory notes------Unqualified opinion------Unqualified opinion
Auditor --Beijing Dahua International Accounting Firm (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg